WHO SAYS IT AWAITS FULL CLINICAL DATA FROM MERCK ON ANTIVIRAL PILL MOLNUPIRAVIR
Tue 12 October 2021: A WHO spokesman said on Tuesday that the World Health Organization is awaiting comprehensive clinical data on Merck & Co Inc’s antiviral pill for treating mild-to-moderate COVID-19 patients, a day after the firm announced it has requested for emergency use authorisation in the United States. WHO spokesperson Christian Lindmeier, asked at […]
Continue Reading
